Literature DB >> 18591054

Quantification of motor slowness in Parkinson's disease: Correlations between the tapping test and single joint ballistic movement parameters.

T Boraud1, F Tison, C Gross.   

Abstract

The tapping test is used routinely for the quantification of drug effects on motor slowness in Parkinson's disease (FD). This test has not been validated previously using reference methods measuring kinematic parameters of movement. We compared and correlated modifications of the tapping score induced by levodopa with that of kinematic parameters of a single joint ballistic movement in 10 PD patients. Results demonstrate that the modification of the tapping score correlates with the bradykinetic, but not the akinetic, component of motor slowness in PD. Also analyzed are the sensitivity and specificity of different thresholds of the increment of the tapping score for the detection of modifications in amplitude, velocity and acceleration. Using a tapping score threshold of positivity between 10 and 20% of increase, the sensitivity and specificity to detect significant modifications in velocity is 100%.

Entities:  

Year:  1997        PMID: 18591054     DOI: 10.1016/s1353-8020(96)00039-9

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  [A biomechanical analysis of cyclical hand motor function: a pilot study in different Parkinsonian syndromes].

Authors:  T Wolfsegger; I Rotaru; R Topakian; R Pichler; M Sonnberger; F T Aichner; H Schwameder
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

2.  The modified bradykinesia rating scale for Parkinson's disease: reliability and comparison with kinematic measures.

Authors:  Dustin A Heldman; Joseph P Giuffrida; Robert Chen; Megan Payne; Filomena Mazzella; Andrew P Duker; Alok Sahay; Sang Jin Kim; Fredy J Revilla; Alberto J Espay
Journal:  Mov Disord       Date:  2011-04-29       Impact factor: 10.338

3.  Effects of a dopamine agonist on the pharmacodynamics of levodopa in Parkinson disease.

Authors:  Matthew A Brodsky; Byung S Park; John G Nutt
Journal:  Arch Neurol       Date:  2010-01

4.  Population pharmacodynamics of IPX066: an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease.

Authors:  Zhongping Mao; Ann Hsu; Suneel Gupta; Nishit B Modi
Journal:  J Clin Pharmacol       Date:  2013-02-20       Impact factor: 3.126

5.  Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease.

Authors:  John G Nutt; Carolin Curtze; Amie Hiller; Shannon Anderson; Paul S Larson; Amber D Van Laar; R Mark Richardson; Marin E Thompson; Alexander Sedkov; Mika Leinonen; Bernard Ravina; Krystof S Bankiewicz; Chadwick W Christine
Journal:  Mov Disord       Date:  2020-03-09       Impact factor: 10.338

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.